Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
11-50
employees, estimated range
Backers
1
Scribble Ventures
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Ancilia Bio201-500 employees
CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia.
Cell MicrosystemsVenture round $6.5M · 3 yr ago • Founded 2021 • 51-200 employees
Cell Microsystems develops innovative tools that allow researchers to image, sort, and isolate single cells and colonies for use in the…
Seek LabsVenture round $2.7M · 22 mo ago • Founded 2024 • 201-500 employees • 1 role
Seek Labs pioneers sequence-agnostic CRISPR therapeutics and AI-driven molecular diagnostics — engineered to map, target, and address…
Pencil Biosciences is pioneering the next generation of gene editing. We are developing a fully synthetic, RNA-guided platform designed to…
Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies…
ProfluentVenture round $106M · 10 mo ago • Founded 2022 • 51-200 employees • 16 roles
Profluent is a company founded in 2022 that trains large language models on protein sequences to design new functional proteins. It…

Overview

The RNA covalency company. Endura's small molecule drugs form an enduring bond with an mRNA, blocking translation and knocking down disease-causing proteins. Gene-level precision like CRISPR, but in a pill.